BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
T cell differentiation
,
Ischemia
,
Adipose tissue
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
long-chain fatty-acyl-CoA metabolic process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Spinal cord
Adipose tissue
Nodose nucleus
Corpus callosum
Medulla
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Injury of external ear
Contact dermatitis
Infection due to Porphyromonas
Sepsis due to Escherichia coli
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Apitolisib
everolimus
GSK-1059615
A-66
MK 1775
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NOP2
GNAI2
FN1
FUBP3
MUTYH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Hemin treatment, GATA1, EKLF or NF-E2 over-expressing and knocking-down in K562 cells
Programming human pluripotent stem cells into adipocytes
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for long-chain fatty-acyl-CoA metabolic process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects
High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders
An Open-label Phase 2 Study of UX007 (Triheptanoin) in Subjects With Long-Chain Fatty Acid Oxidation…
Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorder…
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ